Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy…
| Price | $22.91 |
|---|---|
| Market cap | $11.84B |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NYSE |
| 52-week range | 15.73-30 |
| Dividend (TTM) | $0.04 per share |
| Beta | 0.6 |
Explore BAX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.